2014 Faculty Publications

  1. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH: Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. NeuroImage 2003; 20: 1714-1722.
  2. Stark J, Cross AH: Differential Expression of Suppressors of Cytokine Signaling-1 and -3 and Related Cytokines in Central Nervous System During Remitting versus Non-remitting Forms of Experimental Autoimmune Encephalomyelitis. Int Immunol 2006; 18:347-353.
  3. Cross AH, Stark JL, Ramsbottom MJ, Lauber J, Lyons JA: Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 2006; 180:63-70.
  4. Lyons JA, Ramsbottom MJ, Mikesell RJ, Cross AH: B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice. J Autoimmunity 2008; 31: 149-155.
  5. Piccio LM, Stark JL, Cross AH: Chronic Calorie Restriction Attenuates Experimental Autoimmune Encephalomyelitis. J Leuk Biol 2008; 84:940-948.
  6. Xu J, Sun S-W, Naismith RT, Snyder AZ, Cross AH, Song SK: Assessing Optic Nerve Pathology with Diffusion MRI: from Mouse to Human. NMR Biomed 2008; 21: 928-40. PMCID: PMC2603138
  7. Piccio LM, Buonsanti C, Schmidt RE, Rinker J, Panina-Bordignon P, Cella M, Colonna M, Cross AH: Identification of a novel soluble TREM-2 protein in the cerebrospinal fluid in association with central nervous system inflammation. Brain 2008; 131: 3081-3091
  8. Pitt D, Gonzalez E, Cross AH, Goldberg MP. Dysmyelinated axons in shiverer mice are highly vulnerable to α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated toxicity. Brain Res. 2010; 1309:146-54. PMID: 19896473
  9. Naismith RT, Xu J, Tutlam N, Scully PT, Trinkaus K, Snyder AZ, Song SS, Cross AH. Increased Diffusivity in Acute Multiple Sclerosis Lesions Predicts Risk of Black Holes. Neurology 2010; 74:1694-701. PMID: 20498437
  10. Naismith RT, Piccio L, Lyons JA, Lauber J, Tutlam NT, Parks BJ, Trinkaus K, Song SK, Cross AH: Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology 2010; 74: 1860-1867 PMCID: PMC2882224
  11. Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH. Changes in B and T lymphocytes and chemokines with rituximab treatment in multiple sclerosis. Arch Neurol 2010; 67: 707-714. PMCID: PMC2918395
  12. Wang Y, Wang Q, Haldar JP, Yeh FC, Xie M, Sun P, Trinkaus K, Klein RS, Cross AH, Song S-K. Quantification of increased cellularity during inflammatory demyelination. Brain 2011; 134: 3587-9 PMCID: PMC3235568
  13. Klawiter EC, Xu J, Naismith RT, Benzinger TLS, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Mult Scler 2012;18: 1259-68. PMCID: PMC3360125.
  14. Naismith RT, Xu J, Tutlam NT, Lancia S, Trinkaus K, Song SK, Cross AH. Diffusion Tensor Imaging in Acute Optic Neuropathies. Predictor of Clinical Outcomes. Arch Neurol 2012; 69: 65-71. PMCID:PMC3489058glycoprotein antibodies in Multiple Sclerosis. Arch Neurol. 2010; 67: 1102-1108.
  15. Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT, Cross AH. CXCL13 is a Biomarker of Inflammation in Multiple Sclerosis, Neuromyelitis Optica, and Other Neurological Conditions. Mult Scler. 2013;19:1204-8. PMCID: PMC3959125
  16. Naismith RT, Xu J, Klawiter EC, Lancia S, Tutlam NT, Wagner JM, Qian P, Trinkaus K, Song SK, Cross AH. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. 2013; 8 137.
  17. Luo J, Yablonskiy DA, Lancia S, Hildebolt C, Cross AH. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions. Mult Scler J 2013; 20: 349-355. PMID: 238368760:2201-9. PMCID:PMC3721096
  18. Wang Y, Sun P, Wang Q, Trinkaus K, Naismith RT, Cross AH, Song SK. Differentiation and quantification of inflammation, demyelination, and axon injury/loss in MS. Brain.2015;138(Pt 5):1223-38. PMCID pending
  19. Longbrake EE, Cross AH. Dimethyl Fumarate Associated Lymphopenia in Clinical Practice. Mult Scler. 2015; 21:796-7. PMCID: PMC44260201.
  20. Longbrake EE, Wu GF, Parks BJ, Naismith RT, Cross AH. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance. Mult Scler J: Exp Transl Clin. (in press)
  21. Wen J, Yablonskiy D, Luo J, Lancia S, Hildebolt C, Cross AH. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI NeuroImage: Clinical (in press)
  22. Patel K, Luo J, Alvarez E, Piccio L, Schmidt RE, Yablonskiy DA, Cross AH. Detection of Cortical Lesions in Multiple Sclerosis: An Efficient New Imaging Approach. Mult Scler J: Exp, Transl Clin (in press)